Protective effects of vitamins E, B and C and l-carnitine in the prevention of cisplatin-induced ototoxicity in rats

Journal of Laryngology and Otology

Volumn 126, Issue 5, 2012, Pages 464-469

  Tokgöz, S Alicura ^a   Vuralkan, E ^a   Sonbay, N D ^a   Caliskan M ^b   Saka, C ^a   Besalti O ^b   Akin, I ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Cisplatin; Ear, Inner; Ototoxicity; Rat

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARNITINE; CISPLATIN; UNCLASSIFIED DRUG; VITABIOL C; VITAMIN B COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; BRAIN STEM RESPONSE; CONTROLLED STUDY; EXPERIMENTAL STUDY; MALE; NONHUMAN; OTOACOUSTIC EMISSION; OTOTOXICITY; RANDOMIZED CONTROLLED TRIAL; RAT; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE; WISTAR ALBINO GLAXO RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; CARNITINE; CISPLATIN; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HEARING LOSS; HUMANS; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, WISTAR; SIGNAL-TO-NOISE RATIO; VITAMIN B COMPLEX; VITAMIN E;

EID: 84860830204     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112000382     Document Type: Article

References (35)

1. Jordan J, Schwade ND, Truelson JM. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum. Laryngoscope 1999;109:1259-62 (Pubitemid 29379436)
2. Fram RJ. Cisplatin and platinum analogues: recent advances. Curr Opin Oncol 1992;4:1073-9
3. Guneri EA, Serbetçioglu B, Ikiz AO, Guneri A, Ceryan K. TEOAE monitoring of cisplatin induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment. Auris Nasus Larynx 2001;28:9-14 (Pubitemid 32008620)
4. Feghali JG, Liu W, Water TRVD. L-N-acetyl-cysteine protection against cisplatin induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111:1147-55 (Pubitemid 32625400)
5. Cardinaal RM, De Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 2000;144:135-46 (Pubitemid 30301682)
6. Blakley BW, Cohen JI, Doolittle ND, Muldoon LL, Campbell KC, Dickey DT et al. Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope 2002;112:1997-2001 (Pubitemid 35283462)
7. Lynch ED, Gu R, Pierce C, Kil J. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 2005;201:81-9 (Pubitemid 40255547)
8. Rybak LP, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 1999;109:1740-4 (Pubitemid 29533912)
9. Ekborn A, Anderssen A, Ehrsson H, Eksborg S, Laurell G, Wallin I. Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig. Hear Res 2000;140:38-44 (Pubitemid 30079633)
10. Schweitzer VG. Cisplatin-induced ototoxicity: effect of pigmentation and inhibitory agents. Laryngoscope 1993;103:1-52 (Pubitemid 23139805)
11. Sakamoto M, Kaga K, Kamio T. Extended high-frequency oto-toxicity induced by the first administration of cisplatin. Otolaryngol Head Neck Surg 2000;122:828-33 (Pubitemid 30412647)
12. Reddel RR, Kefford RF, Grant JM, Coats AS, Fox RM, Tattersall MHN. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep 1982;66:19-23 (Pubitemid 12254659)
13. Rybak LP, Husain K, Evenson L, Morris C, Whitworth C, Somani SM. Protection by 4-methylthiobenzoic acid against cis-platin-induced ototoxicity: antioxidant system. Pharmacol Toxicol 1997;81:173-9 (Pubitemid 27432572)
14. Saito T, Aran JM. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL J Otorhinolaryngol Relat Spec 1994;56:315-20 (Pubitemid 24330338)
15. Giordano P, Lorito G, Ciorba A, Martini A, Hatzopoulos S. Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model. Acta Otolaryngol Ital 2006;26:198-207
16. Blumenreich MS, Woodcock TM, Richman SP, Jones MK, Gentile PS, Kubota TT et al. High dose cisplatin in patients with advanced malignancies. Cancer 1985;55:1118-22 (Pubitemid 15128675)
17. Li G, Frenz DA, Brahmblatt S, Feghali JG, Ruben RJ, Berggren D et al. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001;22: 163-76 (Pubitemid 32499698)
18. Ajith TA, Usha S, Nivitha V. Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxi-city in mice: a comparative study. Clin Chim Acta 2007;375: 82-6 (Pubitemid 44584223)
19. Ajith TA, Abhishek G, Roshny D, Sudheesh NP. Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Exp Toxicol Pathol 2009;61:565-71
20. Wimmer C, Mees K, Stumpf P, Welsch U, Reichel O, Suckfüll M. Round window application of D-methionine, sodium thiosul-fate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol 2004; 25:33-40 (Pubitemid 39077568)
21. Campbell KCM, Larsen DL, Meech RP, Rybak LP, Hughes LF. Glutathione ester but not glutathione protects against cisplatin-induced ototoxicity in a rat model. J Am Acad Audiol 2003; 14:124-33
22. Hyppolito MA, de Oliveira JA, Rossato M. Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol 2006;263:798-803 (Pubitemid 44127303)
23. Kamimura T, Whitworth CA, Rybak LP. Effect of 4-methylthio-benzoic acid on cisplatin-induced ototoxicity in the rat. Hear Res 1999;131:117-27 (Pubitemid 29210401)
24. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 2001;174:27-34 (Pubitemid 32635003)
25. Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol 2000;21:513-20 (Pubitemid 30432460)
26. Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EG, Berger HM, Cleton FJ et al. Cisplatin combination chemotherapy induces a fall in plasma anti-oxidants of cancer patients. Ann Oncol 1998;9:1331-7 (Pubitemid 29045573)
27. Teranishi M, Nakashima T, Wakabayashi T. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs. Hear Res 2001;151:61-70
28. Hatano M, Uramoto N, Okabe Y, Furukawa M, Ito M. Vitamin E and vitamin C in the treatment of idiopathic sudden sensori-neural hearing loss. Acta Otolaryngol 2008;128:116-21
29. Freitas MR, Silva VC, Brito GA, Carvalho JV Jr, Gomes RM Jr, Ribeiro R de A. Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cispla-tin-induced ototoxicity in rats. Braz J Otorhinolaryngol 2009; 75:476-84
30. Shaw NA. The auditory evoked potential in the rat-a review. Prog Neurobiol 1988;31:19-45
31. Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cis-platin ototoxicity. Laryngoscope 2004;114:538-42
32. Leonetti C, Biroccio A, Gabellini C, Scarsella M, Maresca V, Flori E et al. Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy. Int J Cancer 2003;104:243-50 (Pubitemid 36249802)
33. Seidman MD, Khan MJ, Bai U, Shirwany N, Quirk WS. Biologic activity of mitochondrial metabolites on aging and age-related hearing loss. Am J Otol 2000;21:161-7 (Pubitemid 30137069)
34. Bielefeld EC, Coling D, Chen GD, Henderson D. Multiple dosing strategies with acetyl L-carnitine (ALCAR) fail to alter age-related hearing loss in the Fischer 344/NHsd rat. J Negat Results Biomed 2008;7:4
35. Coleman JK, Kopke RD, Liu J, Ge X, Harper EA, Jones GE et al. Pharmacological rescue of noise induced hearing loss using N-acetylcysteine and acetyl-L-carnitine. Hear Res 2007; 226:104-13 (Pubitemid 46428031)